GPC3 and hepatocellular carcinoma: There are several clinical trials that are ongoing using GPC3 CAR-T cells for HCC, such as, NCT03146234, NCT03884751, NCT03130712, NCT03198546, NCT02715362, NCT04121273, NCT02959151, NCT03084380 and NCT03302403.